August 24, 2012, Los Angeles, CA. Samantha Lynn Inc. is voluntarily recalling Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.